Skip to main content
Clinical Trials/JPRN-jRCTs031180366
JPRN-jRCTs031180366
Recruiting
未知

Exploratory Clinical Study on the Effectiveness of Glycyrrhizin in Early Vascular Lesions of Systemic Sclerosis

Sumida Hayakazu0 sites20 target enrollmentMarch 18, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Systemic sclerosis
Sponsor
Sumida Hayakazu
Enrollment
20
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 18, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sumida Hayakazu

Eligibility Criteria

Inclusion Criteria

  • 1\)systemic sclerosis patients (Ministry of Health, Labor and Welfare Japan, diagnostic criteria 2016\)
  • 2\)Patients whose age ranges from 20 years to under 80 when acquiring consent
  • 3\)After receiving sufficient explanation for the participation of this study, patients who obtained document consent by the patient's free will with sufficient understanding

Exclusion Criteria

  • 1\)Patients with aldosteronism, myopathy or hypokalemia
  • 2\)Patients with cirrhosis with more than 70 microgram/dL serum ammonia concentration
  • 3\)Patients less than 3 months after the final administration of the other test drugs or investigational drugs
  • 4\)Patients with more than 10 MRSS (modified Rodnan total skin thickness score)
  • 5\)Patients with not satisfy% VC 80% and % DLCO 70% in respiratory function test
  • 6\)Patients with eGFR less than 45 mL / min / 1\.73 m2
  • 7\)Patients with more than RVSP\>40mmHg pulmonary hypertension
  • 8\)Patients with complications of systemic lupus erythematosus or dermatomyositis
  • 9\)Patients with a history of malignant tumors
  • 10\)Patients with a history of severe hypersensitivity or anaphylactic reaction to the components of test drug

Outcomes

Primary Outcomes

Not specified

Similar Trials